Eventide Asset Management »

Lexeo Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $53M 3.4M 15.68
2023-12-31 $40M 3.0M 13.42

More positions owned by Eventide Asset Management

Trane Technologies SHS (TT)
Zentalis Pharmaceuticals (ZNTL)
Shockwave Med (SWAV)
Old Dominion Freight Line (ODFL)
Roper Industries (ROP)
Waste Connections (WCN)
The Trade Desk Com Cl A (TTD)
Celldex Therapeutics Com New (CLDX)
D.R. Horton (DHI)
Datadog Cl A Com (DDOG)
IDEXX Laboratories (IDXX)
Pool Corporation (POOL)
Flywire Corporation Com Vtg (FLYW)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)
Mettler-Toledo International (MTD)

View all positions for Eventide Asset Management

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics